Washington Post August 3, 2021
Alexandra Ellerbeck

with Paige Winfield Cunningham

The U.S. has gotten a crash course over the past 18 months in just how important the biomedical research pipeline can be, as scientists turned years of basic science research into highly effective vaccines against the coronavirus in record-time.

Now, lawmakers say the U.S. is due for big investments to its biomedical infrastructure.

Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) are pushing a bill that would build on the 21st Century Cures Act, a major overhaul in biomedical research passed in 2016 designed to speed up the pipeline for medical innovation.

DeGette and Upton have dubbed their new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Cures Act, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Information Blocking Will Cost Hospitals, Other Providers Under Proposed ONC Rules
OpenNotes Lab to Explore AI’s Impact on Patient-Clinician Communications
Patient Portals & Open Notes Increase Referral Access by Up to 40%
Innovation in Population Data Analytics Driven by the 21st Century Cures Act’s API Standards Requirements
What Providers Can Expect for Information Blocking Enforcement

Share This Article